// App-Quantinova.ai

: Longitudinal Blood Biomarker Trajectories in Preclinical Alzheimer’s Disease

Researchers

Presenter

  • Yara Yakoub

Principal Investigators

  • Nicholas J. Ashton

  • Thomas K Karikari

  • Cherie Strikwerda-Brown

  • Laia Montoliu-Gaya

  • Pierre-François Meyer

  • Frederic St-Onge

  • Michael Schöll

  • John Breitner

  • Henrik Zetterberg

  • Kaj Blennow

  • Judes Poirier

  • Sylvia Villeneuve

Medical Centers

  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg

  • Department of Psychiatry and Neurochemistry, Institute of Physiology and Neuroscience, University of Gothenburg

  • McGill Centre for Integrative Neuroscience, McGill University

  • University of Gothenburg,

  • King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute

  • Centre for Studies on Prevention of Alzheimer's disease (StoP-AD Centre), Douglas Mental Health Institute

  • Department of Neurology and Neurosurgery, McGill University, Montreal, Canada

  • Institute of Physiology and Neuroscience, University of Gothenburg

  • Department of Psychiatry, McGill University

  • UCL Queen Square Institute of Neurology

  • McGill University,

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Wallenberg Centre for Molecular and Translational Medicine; University of Gothenburg,

  • Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy, University of Gothenburg

  • UK Dementia Research Institute

  • NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Amyloid beta 40

  • Amyloid beta 42

Drug/Treatment

  • [18F]NAV4694

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved